Pieris: After Doubling, How Much Upside Left For This <$5 Biotech?

Today, we take a detailed look at a small biotech company called Pieris Pharmaceuticals.

The stock has more than doubled recently on a game-changing collaboration deal with a major drug giant.

Can this rally continue?

MORE ON THIS TOPIC